Overview (18 Sep 2026)
Supriya Lifescience Ltd
SUPRIYA
INE07RO01027
Pharmaceuticals
Result was last declared on 13 Aug 2025
5.65
Prev. Close
Previous Close
900.65
Current Close
906.3
Current High
920
Current Low
895.75
52 Week High
1085
52 Week Low
545.65
Resistance 1
918.95
Resistance 2
931.60
Support 1
894.70
Support 2
870.45
Std Deviation
5.56%
DMA 200
762.49
DMA 50
848.70
DMA 20
847.56
Fundamentals and Ratios
Standalone
Trailing EPS
25.98
Forwad EPS
24.51
Trailing P/E
34.88
Forward P/E
36.98
PEG Ratio
2.66
Mkt. Cap (Cr)
Market Cap (Cr)
7294.16
Total Debt(Cr)
Tot. Debt(Cr)
0.00
Reserve (Cr)
1181.64
Book Value
148.97
P/BV Ratio
6.08
ROCE(%)
23.00
ROE
23.00

 

Financial Result
Standalone
TypeJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue189.75276.53206.44199.83145.07827.88
Other Income2.653.482.612.732.6711.49
Total Income192.40280.01209.05202.56147.75839.36
Interest0.370.470.490.420.511.89
Expenditure-151.60-187.88-141.67-134.24-100.34-564.13
PBDT0.000.000.000.000.000.00
Depreciation-8.94-8.50-6.82-6.64-6.45-28.41
PBT40.7992.1366.9268.3247.41274.78
Tax-16.75-17.90-17.25-17.89-12.62-65.66
Equity16.1016.1016.100.0016.1016.10
OPM21.2032.9032.0134.1932.0932.74
Net Profit24.0474.2349.6850.4334.79209.12
NPM12.4926.5123.7625.2323.5524.91
EPS2.999.226.176.27025.98
Consolidated
TypeFY25-26
Revenue827.875
Other Income11.49
Total Income839.36
Interest1.89
Expenditure-564.13
PBDT0.00
Depreciation-28.41
PBT274.78
Tax-65.66
Equity16.10
OPM32.74
Net Profit209.12
NPM24.91
EPS25.98
Annual Reports

Corporate Action
Quarterly Result
Dividend
YearDividend TypeAmountRemarkEx Date
2025Final Dividend1.00Final Dividend - Rs. - 1.000004 Sep 2025
2024Final Dividend0.80Final Dividend - Rs. - 0.800020 Sep 2024
2023Final Dividend0.60Final Dividend - Rs. - 0.600015 Sep 2023
Bonus
Split

Mutual Fund Holddings